The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Just for perspective: H1 operating loss doubles, £2.6m debt, leased properties with huge lease liability on the accounts, pining hopes on India, Nepal & Chinese students - many of whom have switched focus from UK to Australia/New Zealand for education since Covid & the huge spread! DYOR
BC
Outlook figures very encouraging. Revenue to exceed pre-pandemic level.
I wood say a good result, we should be in profit for H2 2022.
The one thing that does give me confidence is the way that Boost have been very supportive in the past and appear to be continuing to do so going forward.
Lets see, should get some indication in a couple of weeks time. 2.5 times revenue should land some profit if the interest cost don't go over the roof..
2021 was a crap year - so 3x crap = not so crap. I suspect that marketing costs will be significantly higher and dwarf most of the increase in revenue. I am a holder but think that any sp recovery is still some way off.
H1 2022 revenue is 1.6 X H1 2021 and H2 2022 is to be 3x H2 2021 ..wow...this should be huge...
Great update. Topped up significantly...
Looking good, looks ready for take off. Appears like there was a seller on the loose in the last few weeks, but a few buys have been going through as well. Call it blow for blow maybe lol.
Looking forward to 1p. GLALTH
C. L. N
In place
Good to get more positive news this morning, becoming the preferred supplier to provide student recruitment services in mainland China for UEL.
Would be also good to see the numbers for this year's summer camps, as I see in the website that they start next month.
Decent update on 4th of May, hope it starts moving upwards soon.
If you look at the Malvern House F/B page there are more students appearing in the photos. It would appear that student numbers are climbing.
Yep, this could easly be 1p (10 bag) in next couple of years. All the best!
this is at its low, and ripe for covid recovery
Summer school numbers will tell if Malvern are going in the right direction again. Students will also be starting enquiries for next term, hopefully we should start seeing these figures in the next few weeks.
this one of the radar, ripe for recovery
this seems ripe for recovery, as now international restrictions have been relaxed. its been quite. but hopefully news of numbers returning back to pre covid levels will be a significant boost for the share price
????
Sod all...
What is going on with Malvern?
Good to see some more interest over the last few days and strong buy now back on technical.
December financials will be interesting with us hopefully seeing good progress on the January intake.
I see Malvern have updated some of tge website now and are showing the new sales team. Hopefullt we all start seeing some rewards.
https://www.malverninternational.com/sales-team/
Certainly overdue an update, even the last news update on the website is from 2020. I base my investment on numbers and potential, at the moment none of us know the uptake in September or the current interest/numbers for January classes.
Well this is doing nothing at the minute, expected some news by now on numbers etc being increased.
Still holding but I would like some news on the current intakes and an upbeat forward looking statement.
Mr T
Definitely a good development, this is what we have been waiting for. We shld see the sp start recovering soon provided we get good updates from the co. I’m waiting patiently for the rerate, and keep on topping up now and again especially at these low prices.